Multidrug Resistant Tuberculosis Active Not Recruiting Phase Trials for Clofazimine (DB00845)

Back to Multidrug Resistant Tuberculosis

Also known as: MDR-TB / MDR Tuberculosis / Multidrug-Resistant Tuberculosis / Tuberculosis, Multidrug Resistant / Tuberculosis, MDR / MDR TB / Multi Drug Resistant Tuberculosis / Tuberculosis, Multidrug-Resistant / Multi-Drug Resistant Tuberculosis / TB Multi-drug Resistant / Multidrug resistant tuberculosis (disorder) / Tuberculosis / Tuberculosis (disorder) / Tuberculosis NOS / Tuberculosis NOS (disorder) / Infection TBC / Infection tuberculosis / Infection caused by Mycobacterium tuberculosis (disorder) / TB / Tuberculous (disorder) / Tuberculous (qualifier value) / Tuberculous infections

Indication	Status	Phase
DBCOND0041129 (Multidrug Resistant Tuberculosis)	Active Not Recruiting	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04717908	Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS	Treatment	Bedaquiline (DB08903) Clofazimine (DB00845) Cycloserine (DB00260) Linezolid (DB00601) Pyrazinamide (DB00339)